Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Further preclinical evaluation of FM-VP4

July 18, 2003

Improved efficacy for niacin/lovastatin on lipid profile in hyperlipidemia

July 17, 2003

New GSK-3 inhibitors with potential in diabetes, etc.

July 17, 2003

Novo Nordisk scientists present new glucagon antagonists/inverse agonists in recent patent

July 16, 2003

Novel bone antiresorptive agents covered by Sankyo patent

July 16, 2003

Improved glycemic control reported for nateglinide plus rosiglitazone in type 2 diabetes

July 16, 2003

Aastrom Biosciences receives third NIH grant for stem cell research

July 15, 2003

AstraZeneca claims new cannabinoid CB1 receptor modulators

July 15, 2003

Piperazine orexin antagonists in early development at GSK

July 15, 2003

Theratechnologies completes patient enrollment in phase II ThGRF study

July 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...